Suppr超能文献

抗胸腺细胞球蛋白治疗重型再生障碍性贫血后出现的心动过缓恶化

Worsening bradycardia following antithymocyte globulin treatment of severe aplastic anemia.

作者信息

Godown Justin, Deal Allison M, Riley Kathy, Bailliard Frederique, Blatt Julie

出版信息

J Pediatr Pharmacol Ther. 2011 Jul;16(3):218-21. doi: 10.5863/1551-6776-16.3.218.

Abstract

Immunosuppressive regimens, which include antithymocyte globulin (ATG), are widely used for the treatment of severe aplastic anemia (SAA). However, bradycardia has been reported only as a rare side effect of ATG therapy in the manufacturer's product information and, in rare cases, in the adult literature. We present an adolescent with SAA and preexisting bradycardia who underwent immunosuppression therapy with ATG, methylprednisolone, and tacrolimus and developed profound sinus bradycardia with successive doses of ATG.

摘要

包括抗胸腺细胞球蛋白(ATG)在内的免疫抑制方案被广泛用于治疗重型再生障碍性贫血(SAA)。然而,心动过缓仅在制造商的产品信息中被报告为ATG治疗的罕见副作用,在成人文献中也有罕见病例报道。我们报告一名患有SAA且既往有心动过缓的青少年,其接受了ATG、甲泼尼龙和他克莫司的免疫抑制治疗,并在连续使用ATG后出现了严重的窦性心动过缓。

相似文献

引用本文的文献

4
Antithymocyte Globuline Therapy and Bradycardia in Children.儿童抗胸腺细胞球蛋白治疗与心动过缓
Pathol Oncol Res. 2019 Apr;25(2):487-492. doi: 10.1007/s12253-018-0403-y. Epub 2018 Mar 9.

本文引用的文献

2
Sinus bradycardia after intravenous pulse methylprednisolone.静脉注射脉冲式甲泼尼龙后出现窦性心动过缓。
Pediatrics. 2007 Mar;119(3):e778-82. doi: 10.1542/peds.2006-0029. Epub 2007 Feb 16.
3
A delayed cardiopulmonary reaction to an intravenous immunosuppressant thymoglobulin after pancreas transplant.
Anesth Analg. 2001 Nov;93(5):1260-1, table of contents. doi: 10.1097/00000539-200111000-00044.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验